How to Buy Milestone Scientific Stock
Milestone Scientific Inc
Milestone Scientific, Inc. is a biomedical technology research and development company. The company is headquartered in Livingston, New Jersey and currently employs 16 full-time employees.
Milestone Scientific stock last closed at $0.95, down 2.16% from the previous day, and has increased 55.99% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.97 percentage points. Milestone Scientific stock is currently +64.93% from its 52-week low of $0.58, and -31.8% from its 52-week high of $1.39.
At the moment, there are 78.38M MLSS shares outstanding. The market cap of MLSS is $74.46M. In the last 24 hours, 23,303 MLSS shares were traded.
How to Buy Milestone Scientific Stock
Not sure how to invest in Milestone Scientific stock? Here's how.
- Choose where to buy Milestone Scientific stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you decide where to buy Milestone Scientific stock.
- Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit money your brokerage account: Choose your method of payment and add your info.
- Research Milestone Scientific stock: The Milestone Scientific ticker symbol is MLSS. Is Milestone Scientific stock a good investment? Should you buy shares of MLSS? How do MLSS's underlying business fundamentals look? Do top analysts think Milestone Scientific is a good buy? Why has MLSS's stock price moved recently? (Hint: Our stock research tools can help you evaluate if MLSS is a good stock to buy).
- Make your MLSS trade: Decide if you will purchase MLSS shares at the current market price or use a limit order to purchase MLSS shares at a specific price.
- Get the latest news on your MLSS position: Create a watchlist to get live updates on your new investment in Milestone Scientific stock.
Step 1: Choose where to buy Milestone Scientific stock
You need an online brokerage account in order to access the NYSEMKT market and buy MLSS shares.
Our recommended brokerage: eToro
We believe that eToro is the best brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Technology to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top stock exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create your brokerage account
Now that you've selected your brokerage, you'll need to fill out some personal details so you are able to invest in MLSS stock today.
How to Open a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal info to start a new brokerage account.
- Submit your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Deposit money your brokerage account
Now that you have filled out your info on apps for stock market, you need to deposit funds:
Check out the tutorial below to see the process of transferring funds into your new brokerage account.
Step 4: Research Milestone Scientific stock
After you have chosen the best place to buy Milestone Scientific stock, it's important to evaluate their stock before you buy, so you can wrap your head around the risk as well as the opportunity.
Milestone Scientific Metrics
MLSS Fundamentals
WallStreetZen was designed to help average investors perform more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on MLSS's stock page.
Is MLSS stock undervalued or overvalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge MLSS's true value.
Using relative valuations metrics:
- MLSS could be overvalued based on its P/B ratio of 12.77x, relative to Medical Instruments & Supplies industry P/B ratio of 3.73x
You can do more valuation research on MLSS's stock here.
MLSS Financial Health Overview
Passed Health Checks:
- There are more short-term assets than long-term liabilities on the MLSS balance sheet.
- MLSS has cash burn of 2929999. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the MLSS balance sheet.
- MLSS has $3.26M in cash and short term investments. This is sufficient to cover its annual cash burn of $2.93M.
- Total MLSS debt is lower than 5 years ago, relative to shareholder equity.
Failed Health Checks:
- MLSS profit margin has gone up by 0.16 percentage points in the past year, but the company is still unprofitable.
- MLSS has a relatively high debt to equity ratio of 0.68.
Is it a good time to buy Milestone Scientific stock, according to Wall Street analysts?
Out of 1 sell side analysts who monitor MLSS, the consensus analyst rating on Milestone Scientific is a Buy
It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Milestone Scientific stock forecast page.
MLSS Trading Indicators
Is MLSS Making Money?
Last year, MLSS revenue was $8.63M. Over the past five year, MLSS's revenue has gone up by 0.6% per year. This was slower than the Medical Instruments & Supplies industry average of 9.11%.
You can research MLSS's earnings and revenue performance here.
Latest Insiders Trades at MLSS
In the past 12 months, executives and large shareholders at MLSS have bought more shares than they have sold.
Michael McGeehan, Director of MLSS, was the latest MLSS insider to sell. They sold $15,540.00 worth of MLSS shares on Dec 19, 2024.
Get more info about who owns MLSS stock here.
Can I rely on MLSS as an income stream?
No, Milestone Scientific doesn't provide an income stream by paying out dividends.
What others are saying about MLSS
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Make your MLSS trade
There are two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally the easiest way to buy. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to make sure you're buying or selling at a particular price, use a limit order.
Click the Open Trade button and eToro will place the order.
If you need additional help investing in stocks on eToro, watch the helpful video below:
Step 6: Get the latest news on your MLSS position
Now that you own some MLSS shares, you'll want to keep up with your investment.
Create a watchlist to monitor your MLSS stock.
MLSS Feed
How to Buy Stock in Milestone Scientific
To summarize, here are the 6 steps to buy Milestone Scientific stock:
- Choose where to buy Milestone Scientific stock
- Create your brokerage account
- Deposit money your brokerage account
- Research Milestone Scientific stock
- Make your MLSS trade
- Get the latest news on your MLSS position
If you require a online brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to track your investment in Milestone Scientific, create a watchlist on WallStreetZen today.
Other Articles You May Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.